Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Penetration of Topical Tacrolimus
NCT02794610Unknown
- Sponsor
- The Eye Center and The Eye Foundation for Research in Ophthalmology
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Tacrolimus Ointment 0.1% Iwaki in uveitis and Vernal Keratoconjunctivitis (VKC), sponsored by The Eye Center and The Eye Foundation for Research in Ophthalmology. Primary endpoint: Concentration of tacrolimus in the anterior chamber at 15 minutes. Status: unknown.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
uveitisVernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT02794610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794610.